Literature DB >> 16580943

Herpes simplex virus and Epstein-Barr virus infections in pregnancy: consequences of neonatal or intrauterine infection.

Meytal Avgil1, Asher Ornoy.   

Abstract

Herpes simplex virus (HSV) type 1/2 and Epstein-Barr virus (EBV) belong to the human herpes viruses and are among the most ubiquitous viruses in the adult population. In spite of the fact that a large proportion of women at childbearing age are seropositive to these viruses, especially to HSV, primary or secondary infections with these viruses may occur during pregnancy. Genital HSV, especially in primary infections, may be dangerous to the neonate if infected during delivery, as it can cause a severe neonatal disease. Intrauterine infection causing abortion or stillbirth as well as skin scars (cutaneous manifestations), ophthalmologic findings (chorioretinitis, microphtalmia), and neurological involvement (causing brain damage) is also possible, but relatively rare. Primary infection with EBV during pregnancy with apparent transplacental transmission is rare and only few cases were reported. They main damage was in the heart, eyes and liver. The actual damage to the developing embryo and fetus from maternal HSV and EBV seems to be very small. It should be mentioned that both HSV and EBV seem to be able to cross the placenta and cause, as described by several investigators, placental infection manifested by deciduitis and villitis. These placental pathological changes may increase fetal damage.

Entities:  

Mesh:

Year:  2005        PMID: 16580943     DOI: 10.1016/j.reprotox.2004.11.014

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  28 in total

Review 1.  Applying evolutionary genetics to developmental toxicology and risk assessment.

Authors:  Maxwell C K Leung; Andrew C Procter; Jared V Goldstone; Jonathan Foox; Robert DeSalle; Carolyn J Mattingly; Mark E Siddall; Alicia R Timme-Laragy
Journal:  Reprod Toxicol       Date:  2017-03-04       Impact factor: 3.143

Review 2.  Eczema in pregnancy.

Authors:  Sophie Weatherhead; Stephen C Robson; Nick J Reynolds
Journal:  BMJ       Date:  2007-07-21

Review 3.  Heterogeneous pathways of maternal-fetal transmission of human viruses (review).

Authors:  A Saleh Younes; Márta Csire; Beatrix Kapusinszky; Katalin Szomor; Mária Takács; György Berencsi
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

Review 4.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

5.  Association of Depressed Mood With Herpes Simplex Virus-2 Immunoglobulin-G Levels in Pregnancy.

Authors:  Pao-Chu Hsu; Robert H Yolken; Teodor T Postolache; Theresa M Beckie; Cindy L Munro; Maureen W Groer
Journal:  Psychosom Med       Date:  2016-10       Impact factor: 4.312

6.  Maternal Antibodies to Herpes Virus Antigens and Risk of Gastroschisis in Offspring.

Authors:  Martha M Werler; Samantha E Parker; Klaus Hedman; Mika Gissler; Annukka Ritvanen; Heljä-Marja Surcel
Journal:  Am J Epidemiol       Date:  2016-11-17       Impact factor: 4.897

Review 7.  A report of three cases and review of intrauterine herpes simplex virus infection.

Authors:  Lucila Marquez; Moise L Levy; Flor M Munoz; Debra L Palazzi
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

Review 8.  Trophoblast-microbiome interaction: a new paradigm on immune regulation.

Authors:  Gil Mor; Ja-Young Kwon
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 9.  Environmental factors and their timing in adult-onset multiple sclerosis.

Authors:  Adam E Handel; Gavin Giovannoni; George C Ebers; Sreeram V Ramagopalan
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

10.  A rare infectious cause of severe neonatal skin lesions.

Authors:  Veronique Demeulemeester; Michiel Voeten; Yves Jacquemyn; Ludo Mahieu
Journal:  BMJ Case Rep       Date:  2015-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.